The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. [electronic resource]
Producer: 20020509Description: 198-220 p. digitalISSN:- 0197-2456
- Adult
- Anti-HIV Agents -- therapeutic use
- Clinical Trials, Phase III as Topic -- methods
- Data Collection -- methods
- Disease Progression
- Drug Therapy, Combination
- Female
- HIV Infections -- drug therapy
- Humans
- Injections, Subcutaneous
- Interleukin-2 -- therapeutic use
- Male
- Multicenter Studies as Topic -- methods
- Patient Selection
- Randomized Controlled Trials as Topic -- economics
- Research Design
- Sample Size
- Survival Analysis
- United States
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.